Lucidi Bruno
SEC insider (Form 3/4/5 filer). CIK 0001829622. Director at Atea Pharmaceuticals, Inc. (AVIR). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in BOSTON, MA.
Companies Lucidi Bruno has filed insider reports for
- Atea Pharmaceuticals, Inc. (AVIR): Director
Lucidi Bruno
CIK: 0001829622
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Atea Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect29.6K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
26.7K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
37.7K shares- - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
ExerciseDirect29.6K shares- - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
29.6K shares- - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
41.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 29,600 | - | $0 | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Award Restricted Stock Units | 26,700 | - | - | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 37,700 | - | - | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Exercise | 29,600 | - | - | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award Restricted Stock Units | 29,600 | - | - | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 41,200 | - | - | Direct |
1-6 of 6 transactions